Abstract 15 Safety of DUOC-01, Intrathecal Cord Blood-Derived Cellular Therapy, as an Adjunct to Allogeneic Cord Blood Transplantation in Children with Inherited Metabolic Diseases
Publication
, Conference
Sun, J; Baker, J; Cheatham, L; Millette, D; Prasad, V; Kurtzberg, J
Published in: Stem Cells Translational Medicine
September 6, 2022
Duke Scholars
Published In
Stem Cells Translational Medicine
DOI
EISSN
2157-6580
ISSN
2157-6564
Publication Date
September 6, 2022
Volume
11
Issue
Supplement_1
Start / End Page
S17 / S17
Publisher
Oxford University Press (OUP)
Related Subject Headings
- 4003 Biomedical engineering
- 3206 Medical biotechnology
- 1103 Clinical Sciences
- 1004 Medical Biotechnology
- 0601 Biochemistry and Cell Biology
Citation
APA
Chicago
ICMJE
MLA
NLM
Sun, J., Baker, J., Cheatham, L., Millette, D., Prasad, V., & Kurtzberg, J. (2022). Abstract 15 Safety of DUOC-01, Intrathecal Cord Blood-Derived Cellular Therapy, as an Adjunct to Allogeneic Cord Blood Transplantation in Children with Inherited Metabolic Diseases. In Stem Cells Translational Medicine (Vol. 11, pp. S17–S17). Oxford University Press (OUP). https://doi.org/10.1093/stcltm/szac057.015
Sun, Jessica, Jennifer Baker, Lynn Cheatham, Drew Millette, Vinod Prasad, and Joanne Kurtzberg. “Abstract 15 Safety of DUOC-01, Intrathecal Cord Blood-Derived Cellular Therapy, as an Adjunct to Allogeneic Cord Blood Transplantation in Children with Inherited Metabolic Diseases.” In Stem Cells Translational Medicine, 11:S17–S17. Oxford University Press (OUP), 2022. https://doi.org/10.1093/stcltm/szac057.015.
Sun J, Baker J, Cheatham L, Millette D, Prasad V, Kurtzberg J. Abstract 15 Safety of DUOC-01, Intrathecal Cord Blood-Derived Cellular Therapy, as an Adjunct to Allogeneic Cord Blood Transplantation in Children with Inherited Metabolic Diseases. In: Stem Cells Translational Medicine. Oxford University Press (OUP); 2022. p. S17–S17.
Sun, Jessica, et al. “Abstract 15 Safety of DUOC-01, Intrathecal Cord Blood-Derived Cellular Therapy, as an Adjunct to Allogeneic Cord Blood Transplantation in Children with Inherited Metabolic Diseases.” Stem Cells Translational Medicine, vol. 11, no. Supplement_1, Oxford University Press (OUP), 2022, pp. S17–S17. Crossref, doi:10.1093/stcltm/szac057.015.
Sun J, Baker J, Cheatham L, Millette D, Prasad V, Kurtzberg J. Abstract 15 Safety of DUOC-01, Intrathecal Cord Blood-Derived Cellular Therapy, as an Adjunct to Allogeneic Cord Blood Transplantation in Children with Inherited Metabolic Diseases. Stem Cells Translational Medicine. Oxford University Press (OUP); 2022. p. S17–S17.
Published In
Stem Cells Translational Medicine
DOI
EISSN
2157-6580
ISSN
2157-6564
Publication Date
September 6, 2022
Volume
11
Issue
Supplement_1
Start / End Page
S17 / S17
Publisher
Oxford University Press (OUP)
Related Subject Headings
- 4003 Biomedical engineering
- 3206 Medical biotechnology
- 1103 Clinical Sciences
- 1004 Medical Biotechnology
- 0601 Biochemistry and Cell Biology